Synovial sarcoma is a rare soft tissue cancer that can grow quietly for months or even years before being noticed, making early and accurate diagnosis crucial for the best possible outcome.

Introduction: Who Should Seek Diagnostic Testing

Anyone who notices an unusual lump under their skin should schedule an appointment with a healthcare provider as soon as possible. This is especially important if you’re a young adult or teenager, since synovial sarcoma most commonly affects people under the age of 30, though it can occur at any age. The disease affects about 1,000 people each year in the United States, with males being slightly more affected than females.^[1][4]

It’s particularly important to seek medical attention when a lump appears near large joints like the knee, ankle, shoulder, elbow, or wrist, as these are the most common locations for synovial sarcoma to develop. However, the cancer can form almost anywhere in the body, including the arms, legs, feet, abdomen, and even the lungs. In rare cases, it can develop in the chest, head, or neck.^[1][2]

The challenge with synovial sarcoma is that it grows very slowly and may not cause pain initially. Many people won’t experience any symptoms until the tumor becomes large enough to create a visible or palpable lump. This slow growth means tumors can develop undetected for up to two years before diagnosis. During this silent period, the absence of symptoms doesn’t mean absence of disease.^[1][16]

You should be especially alert if you experience symptoms such as swelling in a specific area, a lump that you can feel deep in the tissue, pain that persists for a long time, numbness, or joint stiffness. These symptoms can occur when the tumor grows large enough to press on nearby nerves or structures. However, it’s important to remember that even painless lumps deserve medical evaluation.^[2][5]

Diagnostic Methods for Identifying Synovial Sarcoma

Initial Clinical Evaluation

The diagnostic journey typically begins with a visit to your primary healthcare provider. During this initial appointment, the provider will perform a thorough physical examination and ask detailed questions about your symptoms, including when you first noticed the lump, whether it has grown, if you experience pain, and your overall health history. If the provider suspects synovial sarcoma or another serious condition, they will refer you to an oncologist, a doctor who specializes in diagnosing and treating cancer.^[1][10]

Imaging Tests

Once you’re referred to a specialist, several imaging tests will be ordered to visualize the tumor, determine its size and exact location, and check whether the cancer has spread to other parts of the body. These imaging studies are essential for creating a complete picture of the disease before any treatment decisions are made.^[1][6]

The most commonly used imaging tests include:

• X-rays: These are often the first imaging test performed. X-rays use radiation to create pictures of bones and can show if there are any abnormalities in the area where the lump is located.^[1][5]
• Magnetic Resonance Imaging (MRI): An MRI scan is particularly valuable for soft tissue sarcomas because it provides detailed images of muscles, ligaments, tendons, and other soft tissues. The test uses magnets and radio waves rather than radiation to create three-dimensional pictures of the inside of your body. MRI scans can show the exact size of the tumor and its relationship to nearby structures like blood vessels and nerves.^[1][5][9]
• Computed Tomography (CT) Scan: A CT scan combines multiple X-ray images taken from different angles to create cross-sectional views of bones, blood vessels, and soft tissues. CT scans are particularly useful for detecting whether the cancer has spread to the lungs or other organs.^[1][5]
• Ultrasound: This test uses sound waves to create real-time images of soft tissues. It can help distinguish between solid tumors and fluid-filled cysts, and it’s non-invasive and painless.^[1]
• Positron Emission Tomography (PET) Scan: A PET scan measures important body functions and can show whether cancer has spread to other parts of the body. It can also help determine if a treatment is working by showing changes in how the tumor uses energy.^[5]
• Bone Scans: These tests may be ordered if doctors need to determine whether the cancer has affected nearby bones.^[5]

Biopsy: The Definitive Diagnostic Test

While imaging tests can show where a tumor is located and how large it is, they cannot definitively determine whether the tumor is cancerous or what specific type of cancer it might be. For this reason, a biopsy is essential. During a biopsy, a small sample of tissue is removed from the tumor and examined under a microscope by a specialist called a pathologist.^[1][6][9]

There are different ways to obtain a biopsy sample. Sometimes the tissue can be removed using a needle that is inserted through the skin and into the tumor. This is called a needle biopsy. In other cases, a surgical procedure may be necessary to obtain an adequate tissue sample. The choice of biopsy method depends on the tumor’s location, size, and depth within the body.^[1][6][9]

Once the tissue sample is collected, it undergoes extensive testing in a laboratory. The pathologist will examine the cells under a microscope to look for specific characteristics of synovial sarcoma. The tissue may also undergo special molecular and genetic tests to look for the hallmark genetic change that defines synovial sarcoma.^[1]

Molecular and Genetic Testing

Synovial sarcoma has a distinctive genetic signature that helps confirm the diagnosis. In more than 90% of cases, there is a specific abnormality involving chromosomes X and 18. This abnormality, called a translocation, occurs when parts of these two chromosomes break apart and rejoin in the wrong way, creating an abnormal fusion gene. This can be thought of like a jigsaw puzzle where pieces that don’t belong together get forced into place.^[1][4][6]

The specific translocation is written as t(X;18)(p11.2;q11.2), and it leads to the creation of abnormal proteins called SS18:SSX fusion proteins. The most common fusion proteins are SS18:SSX1 and SS18:SSX2, though SS18:SSX4 can also occur. These fusion proteins are found in about 95% of patients diagnosed with synovial sarcoma and are considered essential for establishing the diagnosis.^[4][6][7]

Advanced laboratory techniques are used to detect this chromosomal translocation. These molecular tests provide definitive confirmation of synovial sarcoma and help distinguish it from other types of soft tissue tumors that might look similar under a microscope. The diagnosis is typically made based on both the appearance of the cells under the microscope (histology) and confirmation of the presence of the t(X;18) translocation.^[6][7]

Additional Laboratory Tests

Beyond the biopsy and molecular testing, your healthcare team may order various blood tests. While there isn’t a specific blood test for synovial sarcoma, routine blood work can provide information about your overall health and help doctors plan treatment safely. These tests might check your blood cell counts, kidney function, liver function, and other important health markers.^[5]

Staging and Disease Extent Evaluation

After confirming the diagnosis, doctors need to determine the stage of the cancer, which describes how advanced it is. Staging is based on several factors including the size of the tumor, whether it has spread to nearby lymph nodes, and whether it has spread to distant parts of the body (a process called metastasis). If the tumor has not spread beyond its original location and nearby tissues, it is considered localized. If it has spread to the lungs or other organs, it is called metastatic or advanced synovial sarcoma.^[3][5][6]

The imaging tests mentioned earlier play a crucial role in staging. Chest CT scans are particularly important because synovial sarcoma commonly spreads to the lungs. Your healthcare team uses all the information from physical exams, imaging tests, biopsies, and molecular testing to create a comprehensive treatment plan tailored to your specific situation.^[1][5]

Diagnostics for Clinical Trial Qualification

Clinical trials are research studies that test new treatments for diseases, including synovial sarcoma. To participate in a clinical trial, patients must meet specific criteria, known as eligibility requirements. These requirements ensure that the study can be conducted safely and that the results will be meaningful for understanding how well the treatment works.^[3]

Before enrolling in a clinical trial, your healthcare provider will perform specific tests to determine if you qualify. Many of these tests are similar to the standard diagnostic tests already described, but they may be repeated or performed in a particular way to meet the trial’s requirements.^[3]

Tissue Testing and Biomarkers

For many clinical trials testing new therapies for synovial sarcoma, confirmation of the specific genetic fusion protein is required. Your healthcare provider will need to verify that your tumor has the characteristic SS18:SSX fusion protein. This might require a new biopsy or additional testing on previously collected tissue samples. Some trials may specify which type of fusion protein (SS18:SSX1, SS18:SSX2, or SSX4) is required for eligibility.^[3][4]

Certain advanced treatments, particularly newer immunotherapy approaches, may require testing for specific cell markers on the surface of tumor cells. These are called biomarkers. Your healthcare provider will perform tests to see if your tumor expresses the particular biomarkers that the treatment is designed to target. This testing helps ensure that the treatment has the best chance of working for you.^[3]

Disease Status and Imaging Requirements

Clinical trials often have specific requirements about the stage and extent of disease. Some trials only accept patients with advanced or metastatic synovial sarcoma that has not responded to standard treatments, while others may accept patients at earlier stages of disease. You will need recent imaging studies (typically done within a few weeks before enrollment) to document the current size and location of all tumors in your body.^[3]

These imaging tests establish what doctors call a “baseline” measurement. Throughout the clinical trial, the same types of imaging tests will be repeated at specified intervals to track whether tumors are shrinking, staying the same, or growing. This allows researchers to determine if the treatment is effective.^[3]

Overall Health Assessment

Clinical trials also require comprehensive assessment of your overall health to ensure you can safely tolerate the experimental treatment. This typically includes blood tests to check your organ function, particularly your kidneys, liver, bone marrow, and heart. Your doctors need to confirm that these organs are working well enough to handle the treatment and that you don’t have other medical conditions that might make the treatment unsafe.^[3]

Some trials may require specific cardiac tests, such as an electrocardiogram (ECG) or echocardiogram, to evaluate your heart function. This is especially true for trials testing treatments that might affect the heart. Similarly, lung function tests may be required if the treatment could potentially affect breathing or if you have disease in the lungs.^[3]

Previous Treatment History

Clinical trials often have specific requirements about what treatments you’ve already received. Some trials only accept patients who have tried and not responded to at least one or two standard treatment approaches. Your medical records will need to document your complete treatment history, including surgeries, radiation therapy, chemotherapy, and any other treatments. This information helps researchers understand how the new treatment compares to existing options.^[3]